Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: a national cohort study

<h3>Objectives</h3><p dir="ltr">We assessed short-, medium-, and long-term all-cause mortality risks after a primary SARS-CoV-2 infection.</p><h3>Methods</h3><p dir="ltr">A national, matched, retrospective cohort study was conducted in Qa...

Full description

Saved in:
Bibliographic Details
Main Author: Hiam Chemaitelly (439114) (author)
Other Authors: Jeremy Samuel Faust (19483087) (author), Harlan M. Krumholz (9228267) (author), Houssein H. Ayoub (9262512) (author), Patrick Tang (239534) (author), Peter Coyle (787159) (author), Hadi M. Yassine (4675846) (author), Asmaa A. Al Thani (10494576) (author), Hebah A. Al-Khatib (6837266) (author), Mohammad R. Hasan (13777597) (author), Zaina Al-Kanaani (4557205) (author), Einas Al-Kuwari (13777606) (author), Andrew Jeremijenko (11506565) (author), Anvar Hassan Kaleeckal (11847034) (author), Ali Nizar Latif (11570540) (author), Riyazuddin Mohammad Shaik (11847037) (author), Hanan F. Abdul-Rahim (13777600) (author), Gheyath K. Nasrallah (9200525) (author), Mohamed Ghaith Al-Kuwari (4264192) (author), Adeel A. Butt (3697705) (author), Hamad Eid Al-Romaihi (6837251) (author), Mohamed H. Al-Thani (11847049) (author), Abdullatif Al-Khal (11721410) (author), Roberto Bertollini (9538620) (author), Laith J. Abu-Raddad (9262524) (author)
Published: 2023
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864513507072933888
author Hiam Chemaitelly (439114)
author2 Jeremy Samuel Faust (19483087)
Harlan M. Krumholz (9228267)
Houssein H. Ayoub (9262512)
Patrick Tang (239534)
Peter Coyle (787159)
Hadi M. Yassine (4675846)
Asmaa A. Al Thani (10494576)
Hebah A. Al-Khatib (6837266)
Mohammad R. Hasan (13777597)
Zaina Al-Kanaani (4557205)
Einas Al-Kuwari (13777606)
Andrew Jeremijenko (11506565)
Anvar Hassan Kaleeckal (11847034)
Ali Nizar Latif (11570540)
Riyazuddin Mohammad Shaik (11847037)
Hanan F. Abdul-Rahim (13777600)
Gheyath K. Nasrallah (9200525)
Mohamed Ghaith Al-Kuwari (4264192)
Adeel A. Butt (3697705)
Hamad Eid Al-Romaihi (6837251)
Mohamed H. Al-Thani (11847049)
Abdullatif Al-Khal (11721410)
Roberto Bertollini (9538620)
Laith J. Abu-Raddad (9262524)
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author_facet Hiam Chemaitelly (439114)
Jeremy Samuel Faust (19483087)
Harlan M. Krumholz (9228267)
Houssein H. Ayoub (9262512)
Patrick Tang (239534)
Peter Coyle (787159)
Hadi M. Yassine (4675846)
Asmaa A. Al Thani (10494576)
Hebah A. Al-Khatib (6837266)
Mohammad R. Hasan (13777597)
Zaina Al-Kanaani (4557205)
Einas Al-Kuwari (13777606)
Andrew Jeremijenko (11506565)
Anvar Hassan Kaleeckal (11847034)
Ali Nizar Latif (11570540)
Riyazuddin Mohammad Shaik (11847037)
Hanan F. Abdul-Rahim (13777600)
Gheyath K. Nasrallah (9200525)
Mohamed Ghaith Al-Kuwari (4264192)
Adeel A. Butt (3697705)
Hamad Eid Al-Romaihi (6837251)
Mohamed H. Al-Thani (11847049)
Abdullatif Al-Khal (11721410)
Roberto Bertollini (9538620)
Laith J. Abu-Raddad (9262524)
author_role author
dc.creator.none.fl_str_mv Hiam Chemaitelly (439114)
Jeremy Samuel Faust (19483087)
Harlan M. Krumholz (9228267)
Houssein H. Ayoub (9262512)
Patrick Tang (239534)
Peter Coyle (787159)
Hadi M. Yassine (4675846)
Asmaa A. Al Thani (10494576)
Hebah A. Al-Khatib (6837266)
Mohammad R. Hasan (13777597)
Zaina Al-Kanaani (4557205)
Einas Al-Kuwari (13777606)
Andrew Jeremijenko (11506565)
Anvar Hassan Kaleeckal (11847034)
Ali Nizar Latif (11570540)
Riyazuddin Mohammad Shaik (11847037)
Hanan F. Abdul-Rahim (13777600)
Gheyath K. Nasrallah (9200525)
Mohamed Ghaith Al-Kuwari (4264192)
Adeel A. Butt (3697705)
Hamad Eid Al-Romaihi (6837251)
Mohamed H. Al-Thani (11847049)
Abdullatif Al-Khal (11721410)
Roberto Bertollini (9538620)
Laith J. Abu-Raddad (9262524)
dc.date.none.fl_str_mv 2023-11-01T00:00:00Z
dc.identifier.none.fl_str_mv 10.1016/j.ijid.2023.09.005
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/Short-_and_longer-term_all-cause_mortality_among_SARS-CoV-2-_infected_individuals_and_the_pull-forward_phenomenon_in_Qatar_a_national_cohort_study/26830936
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Health sciences
Epidemiology
Public health
Acute infection
Immunity
Death
Long COVID
Cohort study
Epidemiology
dc.title.none.fl_str_mv Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: a national cohort study
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <h3>Objectives</h3><p dir="ltr">We assessed short-, medium-, and long-term all-cause mortality risks after a primary SARS-CoV-2 infection.</p><h3>Methods</h3><p dir="ltr">A national, matched, retrospective cohort study was conducted in Qatar to assess risk of all-cause mortality in the national SARS-CoV-2 primary infection cohort compared with the national infection-naïve cohort. Associations were estimated using Cox proportional-hazards regression models. Analyses were stratified by vaccination status and clinical vulnerability status.</p><h3>Results</h3><p dir="ltr">Among unvaccinated persons, within 90 days after primary infection, the adjusted hazard ratio (aHR) comparing mortality incidence in the primary-infection cohort with the infection-naïve cohort was 1.19 (95% confidence interval 1.02-1.39). aHR was 1.34 (1.11-1.63) in persons more clinically vulnerable to severe COVID-19 and 0.94 (0.72-1.24) in those less clinically vulnerable. Beyond 90 days after primary infection, aHR was 0.50 (0.37-0.68); aHR was 0.41 (0.28-0.58) at 3-7 months and 0.76 (0.46-1.26) at ≥8 months. The aHR was 0.37 (0.25-0.54) in more clinically vulnerable persons and 0.77 (0.48-1.24) in less clinically vulnerable persons. Among vaccinated persons, mortality incidence was comparable in the primary-infection versus infection-naïve cohorts, regardless of clinical vulnerability status.</p><h3>Conclusions</h3><p dir="ltr">COVID-19 mortality was primarily driven by an accelerated onset of death among individuals who were already vulnerable to all-cause mortality, but vaccination prevented these accelerated deaths.</p><h2>Other Information</h2><p dir="ltr">Published in: International Journal of Infectious Diseases<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1016/j.ijid.2023.09.005" target="_blank">https://dx.doi.org/10.1016/j.ijid.2023.09.005</a></p>
eu_rights_str_mv openAccess
id Manara2_9b1b03c7cd20b33211901c4ddae4cd12
identifier_str_mv 10.1016/j.ijid.2023.09.005
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/26830936
publishDate 2023
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: a national cohort studyHiam Chemaitelly (439114)Jeremy Samuel Faust (19483087)Harlan M. Krumholz (9228267)Houssein H. Ayoub (9262512)Patrick Tang (239534)Peter Coyle (787159)Hadi M. Yassine (4675846)Asmaa A. Al Thani (10494576)Hebah A. Al-Khatib (6837266)Mohammad R. Hasan (13777597)Zaina Al-Kanaani (4557205)Einas Al-Kuwari (13777606)Andrew Jeremijenko (11506565)Anvar Hassan Kaleeckal (11847034)Ali Nizar Latif (11570540)Riyazuddin Mohammad Shaik (11847037)Hanan F. Abdul-Rahim (13777600)Gheyath K. Nasrallah (9200525)Mohamed Ghaith Al-Kuwari (4264192)Adeel A. Butt (3697705)Hamad Eid Al-Romaihi (6837251)Mohamed H. Al-Thani (11847049)Abdullatif Al-Khal (11721410)Roberto Bertollini (9538620)Laith J. Abu-Raddad (9262524)Health sciencesEpidemiologyPublic healthAcute infectionImmunityDeathLong COVIDCohort studyEpidemiology<h3>Objectives</h3><p dir="ltr">We assessed short-, medium-, and long-term all-cause mortality risks after a primary SARS-CoV-2 infection.</p><h3>Methods</h3><p dir="ltr">A national, matched, retrospective cohort study was conducted in Qatar to assess risk of all-cause mortality in the national SARS-CoV-2 primary infection cohort compared with the national infection-naïve cohort. Associations were estimated using Cox proportional-hazards regression models. Analyses were stratified by vaccination status and clinical vulnerability status.</p><h3>Results</h3><p dir="ltr">Among unvaccinated persons, within 90 days after primary infection, the adjusted hazard ratio (aHR) comparing mortality incidence in the primary-infection cohort with the infection-naïve cohort was 1.19 (95% confidence interval 1.02-1.39). aHR was 1.34 (1.11-1.63) in persons more clinically vulnerable to severe COVID-19 and 0.94 (0.72-1.24) in those less clinically vulnerable. Beyond 90 days after primary infection, aHR was 0.50 (0.37-0.68); aHR was 0.41 (0.28-0.58) at 3-7 months and 0.76 (0.46-1.26) at ≥8 months. The aHR was 0.37 (0.25-0.54) in more clinically vulnerable persons and 0.77 (0.48-1.24) in less clinically vulnerable persons. Among vaccinated persons, mortality incidence was comparable in the primary-infection versus infection-naïve cohorts, regardless of clinical vulnerability status.</p><h3>Conclusions</h3><p dir="ltr">COVID-19 mortality was primarily driven by an accelerated onset of death among individuals who were already vulnerable to all-cause mortality, but vaccination prevented these accelerated deaths.</p><h2>Other Information</h2><p dir="ltr">Published in: International Journal of Infectious Diseases<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1016/j.ijid.2023.09.005" target="_blank">https://dx.doi.org/10.1016/j.ijid.2023.09.005</a></p>2023-11-01T00:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1016/j.ijid.2023.09.005https://figshare.com/articles/journal_contribution/Short-_and_longer-term_all-cause_mortality_among_SARS-CoV-2-_infected_individuals_and_the_pull-forward_phenomenon_in_Qatar_a_national_cohort_study/26830936CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/268309362023-11-01T00:00:00Z
spellingShingle Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: a national cohort study
Hiam Chemaitelly (439114)
Health sciences
Epidemiology
Public health
Acute infection
Immunity
Death
Long COVID
Cohort study
Epidemiology
status_str publishedVersion
title Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: a national cohort study
title_full Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: a national cohort study
title_fullStr Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: a national cohort study
title_full_unstemmed Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: a national cohort study
title_short Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: a national cohort study
title_sort Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: a national cohort study
topic Health sciences
Epidemiology
Public health
Acute infection
Immunity
Death
Long COVID
Cohort study
Epidemiology